Literature DB >> 19039768

CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.

Shaza A Fadel1, Shannon K Bromley, Benjamin D Medoff, Andrew D Luster.   

Abstract

Mice lacking the chemokine receptor CCR5 are susceptible to mortality from a normally non-lethal influenza infection. Here we found that CXCR3-deficiency rescued CCR5-deficient (CCR5(-/-)) mice from influenza-induced mortality. The number of mononuclear phagocytes in the airways was transiently increased in CCR5(-/-) mice but not in CXCR3-CCR5 double-deficient mice. Antigen-specific CXCR3-CCR5 double-deficient CD8 effector cells were less efficient at entering the airways compared with WT or CCR5(-/-) CD8 effector cells. The decrease in inflammatory cell infiltrates in CXCR3-CCR5 double-deficient-infected mice correlated with a decrease in CCL2 and IFN-gamma production in the airways. Finally, CXCR3-CCR5 double-deficient mice that survived the primary viral challenge were protected from a lethal secondary challenge, indicating that T-cell-mediated protective memory was not compromised in mice lacking these chemokine receptors. In conclusion, CXCR3-deficiency attenuated the lethal cellular immune response in CCR5(-/-) influenza-infected mice without hindering viral clearance or long-term immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19039768      PMCID: PMC2749081          DOI: 10.1002/eji.200838628

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  44 in total

1.  Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

Authors:  M Cella; F Facchetti; A Lanzavecchia; M Colonna
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

2.  Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.

Authors:  M Q Zhao; M H Stoler; A N Liu; B Wei; C Soguero; Y S Hahn; R I Enelow
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

3.  The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia.

Authors:  D J Topham; M R Castrucci; F S Wingo; G T Belz; P C Doherty
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

4.  Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice.

Authors:  S Sakai; H Kawamata; N Mantani; T Kogure; Y Shimada; K Terasawa; T Sakai; N Imanishi; H Ochiai
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology.

Authors:  J A Wiley; A Cerwenka; J R Harkema; R W Dutton; A G Harmsen
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

6.  The role of CC chemokine receptor 5 in antiviral immunity.

Authors:  Anneline Nansen; Jan Pravsgaard Christensen; Susanne Ørding Andreasen; Christina Bartholdy; Jeanette Erbo Christensen; Allan Randrup Thomsen
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

7.  IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.

Authors:  Nir Grabie; Michael W Delfs; Jason R Westrich; Victoria A Love; George Stavrakis; Ferhaan Ahmad; Christine E Seidman; Jonathan G Seidman; Andrew H Lichtman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections.

Authors:  Jacob E Kohlmeier; Shannon C Miller; Joanna Smith; Bao Lu; Craig Gerard; Tres Cookenham; Alan D Roberts; David L Woodland
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

9.  Requirement of the chemokine receptor CXCR3 for acute allograft rejection.

Authors:  W W Hancock; B Lu; W Gao; V Csizmadia; K Faia; J A King; S T Smiley; M Ling; N P Gerard; C Gerard
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

10.  CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.

Authors:  B A Small; S A Dressel; C W Lawrence; D R Drake; M H Stoler; R I Enelow; T J Braciale
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  34 in total

1.  The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Authors:  Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

Review 2.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

3.  Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae.

Authors:  Catarina V Nogueira; Xuqing Zhang; Nicholas Giovannone; Erica L Sennott; Michael N Starnbach
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

4.  A spatial model of the efficiency of T cell search in the influenza-infected lung.

Authors:  Drew Levin; Stephanie Forrest; Soumya Banerjee; Candice Clay; Judy Cannon; Melanie Moses; Frederick Koster
Journal:  J Theor Biol       Date:  2016-02-23       Impact factor: 2.691

5.  CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin.

Authors:  Akihiko Ichikawa; Keiji Kuba; Masayuki Morita; Shinsuke Chida; Hiroyuki Tezuka; Hiromitsu Hara; Takehiko Sasaki; Toshiaki Ohteki; V Marco Ranieri; Claudia C dos Santos; Yoshihiro Kawaoka; Shizuo Akira; Andrew D Luster; Bao Lu; Josef M Penninger; Stefan Uhlig; Arthur S Slutsky; Yumiko Imai
Journal:  Am J Respir Crit Care Med       Date:  2012-11-09       Impact factor: 21.405

6.  CXCR3 in T cell function.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Exp Cell Res       Date:  2011-03-10       Impact factor: 3.905

7.  TGF-β Controls the Formation of Kidney-Resident T Cells via Promoting Effector T Cell Extravasation.

Authors:  Shruti Mishra; Erika L Demel; Chaoyu Ma; Yong Liu; Nu Zhang
Journal:  J Immunol       Date:  2016-11-30       Impact factor: 5.422

Review 8.  Chemokines: Critical Regulators of Memory T Cell Development, Maintenance, and Function.

Authors:  Rod A Rahimi; Andrew D Luster
Journal:  Adv Immunol       Date:  2018-03-26       Impact factor: 3.543

9.  Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3.

Authors:  Steven G Kelsen; Mark O Aksoy; Mary Georgy; Richard Hershman; Rong Ji; Xiuxia Li; Matthew Hurford; Charalambos Solomides; Wissam Chatila; Victor Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

10.  Antibody-suppressor CD8+ T Cells Require CXCR5.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.